NaKtide Peptide Src Inhibitor Targeting Na/K-ATPase Complex
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need to determine the molecular interaction between the Na/K-ATPase and Src to develop novel Src modulators that can antagonize ouabain-induced signal transduction, and to target the Na/K-ATPase/Src receptor complex for therapeutic applications in diseases such as ischemia/reperfusion injury, tissue fibrosis, congestive heart failure, and cancer.
Innovation Solution
A novel peptide Src inhibitor, NaKtide, is developed that targets the Na/K-ATPase/Src receptor complex, antagonizing ouabain-induced protein kinase cascades by binding to the Src kinase domain, and its cell-permeable derivatives, such as pNaKtide, specifically inhibit Src activity in various cellular compartments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional Src inhibitors are used, then Src activity is inhibited, but they lack specificity for the Na/K-ATPase-associated Src pool and have off-target effects
Solution Approach 1:
The peptide inhibitor is designed to specifically target the Na/K-ATPase-associated Src pool rather than inhibiting Src universally. The inhibitor binds to the Na/K-ATPase/Src complex at the plasma membrane, providing localized inhibition specific to the receptor complex while sparing other Src activity sites throughout the cell.
Solution Approach 2:
The peptide acts as an intermediary that binds to the Na/K-ATPase/Src complex, disrupting the interaction between Na/K-ATPase and Src. This intermediary binding selectively prevents ouabain-induced Src activation without directly inhibiting all Src activity, thereby achieving specificity.
2Reliability
If Na/K-ATPase/Src complex is targeted, then ouabain-induced signal transduction is blocked, but the mechanism for achieving this targeting is complex
Solution Approach 1:
The invention extracts the critical binding motif from the Na/K-ATPase protein sequence and uses it to design a peptide inhibitor. By taking out the specific amino acid sequence that interacts with Src, the peptide can selectively disrupt the Na/K-ATPase/Src complex formation, simplifying the targeting mechanism.
Solution Approach 2:
The peptide inhibitor is designed as a short segment (20 amino acids) derived from the Na/K-ATPase protein, specifically from the N-terminus region. This segmentation allows the peptide to act as a discrete molecular tool that can bind to and disrupt the Na/K-ATPase/Src interaction without requiring complex multi-component systems.
3Reliability
If peptide inhibitors are used to achieve high specificity, then off-target effects are reduced, but cell permeability and delivery become challenging
Solution Approach 1:
The peptide sequence is modified by changing physical and chemical parameters such as adding positively charged amino acids (arginine, lysine) at specific positions. These parameter changes enhance the peptide's ability to interact with the negatively charged plasma membrane and improve cell permeability while maintaining its specific binding capability to the Na/K-ATPase/Src complex.
Solution Approach 2:
The peptide is designed as a composite structure combining the core binding motif with functional domains that enhance cell penetration and membrane interaction. This composite design integrates the specificity of the binding motif with the permeability-enhancing properties of charged amino acid sequences.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
NaKtide effectively inhibits Src kinase activity with an IC50 of 70 nM, selectively targeting the Na/K-ATPase-associated Src pool, blocking ouabain-induced activation of ERK1/2, and inhibiting cancer cell growth and angiogenesis, demonstrating potential as a therapeutic agent for cardiovascular and cancer treatments.
Implementation Method 1
binding to the Src kinase domain
Implementation Method 2
inhibits Src kinase activity with an IC50 of 70 nM
Implementation Method 3
The formation of this Na/K-ATPase and Src complex serves as a receptor for ouabain
Implementation Method 4
binding of ouabain to Na/K-ATPase will disrupt the latter interaction
Data Source
AI summary
A novel Src inhibitor that targets the Na/K-ATPase/Src receptor complex and antagonizes ouabain-induced protein kinase cascades and uses thereof are disclosed.